These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group. Stanulla M, Cario G, Meissner B, Schrauder A, Möricke A, Riehm H, Schrappe M. Blood Cells Mol Dis; 2007; 39(2):160-3. PubMed ID: 17532236 [Abstract] [Full Text] [Related]
5. Allogeneic transplantation for childhood ALL. Mehta PA, Davies SM. Bone Marrow Transplant; 2008 Jan; 41(2):133-9. PubMed ID: 17994118 [Abstract] [Full Text] [Related]
6. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Arico M, Ziino O, Valsecchi MG, Cazzaniga G, Baronci C, Messina C, Pession A, Santoro N, Basso G, Conter V, Italian Association of Pediatric Hematology and Oncology (AIEOP). Cancer; 2008 Aug 01; 113(3):515-21. PubMed ID: 18521927 [Abstract] [Full Text] [Related]
7. Advances in acute lymphoblastic leukemia. Randolph TR. Clin Lab Sci; 2004 Aug 01; 17(4):235-45. PubMed ID: 15559730 [Abstract] [Full Text] [Related]
9. Remaining problems in the staging and treatment of childhood lymphoblastic leukemia. Bleyer WA. Am J Pediatr Hematol Oncol; 1989 Jan 01; 11(4):371-9. PubMed ID: 2694853 [Abstract] [Full Text] [Related]
14. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Uderzo C, Conter V, Dini G, Locatelli F, Miniero R, Tamaro P. Haematologica; 2001 Jan 01; 86(1):1-7. PubMed ID: 11146562 [No Abstract] [Full Text] [Related]
15. Treatment of childhood acute myeloid leukemia. ter Bals E, Kaspers GJ. Expert Rev Anticancer Ther; 2005 Oct 01; 5(5):917-29. PubMed ID: 16221060 [Abstract] [Full Text] [Related]
16. Diagnosis and management of relapse in acute lymphoblastic leukemia. Buchanan GR. Hematol Oncol Clin North Am; 1990 Oct 01; 4(5):971-95. PubMed ID: 2262488 [Abstract] [Full Text] [Related]
17. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time. Balduzzi A, De Lorenzo P, Schrauder A, Conter V, Uderzo C, Peters C, Klingebiel T, Stary J, Felice MS, Magyarosy E, Schrappe M, Dini G, Gadner H, Valsecchi MG. Haematologica; 2008 Jun 01; 93(6):925-9. PubMed ID: 18413892 [Abstract] [Full Text] [Related]
18. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference. Herold R, von Stackelberg A, Hartmann R, Eisenreich B, Henze G. J Clin Oncol; 2004 Feb 01; 22(3):569-70; author reply 570-1. PubMed ID: 14752084 [No Abstract] [Full Text] [Related]
19. Risk-adapted treatment of pediatric acute lymphoblastic leukemia. Jeha S, Pui CH. Hematol Oncol Clin North Am; 2009 Oct 01; 23(5):973-90, v. PubMed ID: 19825448 [Abstract] [Full Text] [Related]